Compare · RMD vs UFPT
RMD vs UFPT
Side-by-side comparison of ResMed Inc. (RMD) and UFP Technologies Inc. (UFPT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RMD and UFPT operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD is the larger of the two at $34.13B, about 14.5x UFPT ($2.36B).
- Over the past year, RMD is down 17.0% and UFPT is up 39.0% - UFPT leads by 56.0 points.
- UFPT has been more active in the news (12 items in the past 4 weeks vs 9 for RMD).
- RMD has more recent analyst coverage (25 ratings vs 7 for UFPT).
- Company
- ResMed Inc.
- UFP Technologies Inc.
- Price
- -
- -
- Market cap
- $34.13B
- $2.36B
- 1M return
- +16.50%
- +22.11%
- 1Y return
- -17.04%
- +38.99%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 1993
- News (4w)
- 9
- 12
- Recent ratings
- 25
- 7
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
UFP Technologies Inc.
UFP Technologies, Inc. designs and converts foams, films, and plastics materials for the medical, automotive, consumer, electronics, industrial, and aerospace and defense markets in the United States. It offers single patient use surfaces, advanced wound care, infection prevention, and disposables for surgical procedures, endoscopic procedures, orthopedic implants, orthopedic appliances, biopharma drug manufacturing, etc.; molded components for automotive, aerospace, and defense markets; recycled protective packaging for B2C brands; and reusable cases and custom inserts. The company markets and sells its products through direct sales forces and independent manufacturer representatives. UFP Technologies, Inc. was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Latest RMD
- 23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs
- Rothschild & Co Redburn initiated coverage on ResMed with a new price target
- SEC Form 8-K filed by ResMed Inc.
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- SEC Form 10-K filed by ResMed Inc.
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,026,596 worth of ResMed Common Stock (4,991 units at $205.69) as part of a pre-agreed trading plan (SEC Form 4)
- ResMed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
- Director Farrell Peter C sold $1,800,000 worth of ResMed Common Stock (8,000 units at $225.00) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 52,773 units (SEC Form 4)
- BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD)
Latest UFPT
- UFP Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
- Director Hudson Symeria sold $95,095 worth of shares (298 units at $319.11), decreasing direct ownership by 24% to 927 units (SEC Form 4)
- Director Hudson Symeria sold $625,141 worth of shares (1,926 units at $324.58) and exercised 1,196 shares at a strike of $206.29, decreasing direct ownership by 37% to 1,225 units (SEC Form 4)
- Director Feldmann Cynthia L sold $324,260 worth of shares (1,000 units at $324.26), decreasing direct ownership by 18% to 4,476 units (SEC Form 4)
- Amendment: SEC Form 4 filed by Director Hassett Joseph John
- Executive Chairman Bailly R Jeffrey sold $4,113,221 worth of shares (13,011 units at $316.13) (SEC Form 4)
- Executive Chairman Bailly R Jeffrey sold $4,997,051 worth of shares (15,695 units at $318.38) (SEC Form 4)
- Vice President Holt Jason sold $348,700 worth of shares (1,100 units at $317.00), decreasing direct ownership by 12% to 7,878 units (SEC Form 4)
- SEC Form 10-Q filed by UFP Technologies Inc.